Ergoteles’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,704
Closed -$876K 1500
2023
Q1
$876K Buy
13,704
+7,366
+116% +$481K 0.03% 545
2022
Q4
$308K Buy
6,338
+3,315
+110% +$208K 0.01% 901
2022
Q3
$213K Sell
3,023
-4,179
-58% -$358K 0.01% 1144
2022
Q2
$511K Buy
+7,202
New +$464K 0.02% 828
2022
Q1
Sell
-17,859
Closed -$1.63M 1618
2021
Q4
$1.63M Buy
17,859
+9,181
+106% +$985K 0.06% 295
2021
Q3
$1.11M Buy
+8,678
New +$1.21M 0.04% 352

Other funds holding STAA

Ergoteles's STAA Position: Q2 2023 in Review

Ergoteles sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 13,704 shares — an estimated $876K sold.

Ergoteles first reported a position in STAA in Q3 2021 and held it in 6 quarters. The position peaked at $1.63M in Q4 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Ergoteles reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 13,704 STAAR Surgical shares in Q2 2023, an estimated $876K.
  • Ergoteles first reported a position in STAAR Surgical in Q3 2021 and held it in 6 quarters.
  • Ergoteles's STAAR Surgical position peaked at $1.63M in Q4 2021.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.